फलो गर्नुहोस्
Englishनेपाली
← पछाडि

Desifer 100 DT 100mg Tablet

जेनेरिक: Deferasirox 100mg
Iron chelatorTablet100mg५ ब्रान्ड · ३ निर्माता
Desifer 100 DT भनेको Deferasirox 100mg हो। यो Iron chelator वर्गमा पर्छ। यो Natco Pharma ले बनाएको ब्रान्ड उत्पादन हो। यो Chronic iron overload का लागि प्रयोग हुन्छ। Desifer 100 DT NepalDoc सूचीमा रहेका Natco Pharma का २ वटा Desifer उत्पादनमध्ये एक हो।
ब्रान्ड (Brand)Desifer 100 DT
सामान्य नाम (Generic name)Deferasirox
निर्माता (Maker)Natco Pharma
रूप (Form)Tablet
शक्ति (Strength)100mg
स्रोतNepalDoc medicine catalog

Desifer परिवार

Desifer Natco Pharma को ब्रान्ड परिवार हो, नेपालमा बिक्री हुन्छ। NepalDoc सूचीमा यसका २ वटा उत्पादन छन् — २ वटा औषधि लाइनमा: Iron sucrose, Deferasirox।

Desifer 100mg InjectionIron sucrose · 100mg
Desifer 100 DT 100mg Tablet (यो पृष्ठ)Deferasirox · 100mg

के का लागि

Deferasirox यी अवस्थाका लागि प्रयोग हुन्छ: Chronic iron overload।

NepalDoc औषधि सूचीमा Deferasirox का लागि दर्ता गरिएको।

Deferasirox tablets are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older.

From the U.S. FDA-approved label for Deferasirox. Full label: DailyMed.

Deferasirox tablets are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older. Deferasirox tablets are indicated for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes, and with a liver iron (Fe) concentration (LIC) of at least 5 mg Fe per gram of dry weight (Fe/g dw) and a serum ferritin greater than 300 mcg/L.

From the U.S. FDA-approved label for Deferasirox. Full label: DailyMed.

Transfusional Iron Overload: Initial dose for patients with estimated glomerular filtration rate (eGFR) greater than 60 mL/min/1.73 m 2 is 14 mg per kg (calculated to nearest whole tablet ) once daily. NTDT Syndromes: Initial dose for patients with eGFR greater than 60 mL/min/1.73 m 2 is 7 mg per kg (calculated to nearest whole tablet) once daily. See full prescribing information for information regarding monitoring, administration, and dose-reductions for organ impairment.

Directions from the U.S. FDA-approved label for Deferasirox — your doctor or pharmacist may advise differently.

Deferasirox is contraindicated in patients with: Estimated GFR less than 40 mL/min/1.73 m 2; Poor performance status; High-risk myelodysplastic syndromes (this patient population was not studied and is not expected to benefit from chelation therapy); Advanced malignancies; Platelet counts less than 50 x 10 9 /L; Known hypersensitivity to deferasirox or any component of deferasirox. Estimated GFR less than 40 mL/min/1.73 m 2. Patients with poor performance status. Patients with high-risk myelodysplastic syndrome (MDS). Patients with advanced malignancies.

Excerpt from the U.S. FDA-approved label for Deferasirox. Talk to a pharmacist or doctor before use.

Acute Kidney Injury: Measure serum creatinine in duplicate before starting therapy. Monitor renal function during deferasirox therapy and reduce dose or interrupt therapy for toxicity. Hepatic Toxicity: Monitor hepatic function. Reduce dose or interrupt therapy for toxicity. Fatal and Nonfatal Gastrointestinal (GI) Bleeding, Ulceration, and Irritation: Risk may be greater in patients who are taking deferasirox in combination with drugs that have known ulcerogenic or hemorrhagic potential.

Warnings and precautions excerpt from the U.S. FDA-approved label for Deferasirox — not a complete list. Talk to a pharmacist or doctor before use.

The following clinically significant adverse reactions are also discussed in other sections of the labeling: Acute Kidney Injury, Including Acute Renal Failure Requiring Dialysis, and Renal Tubular Toxicity Including Fanconi Syndrome Hepatic Toxicity and Failure GI Hemorrhage Bone Marrow Suppression Hypersensitivity Severe Skin Reactions Skin Rash Auditory and Ocular Abnormalities In patients with transfusional iron overload,…

Excerpt from the U.S. FDA-approved label for Deferasirox — not a complete list. Talk to a pharmacist or doctor about side effects.

Defrijet 250mg TabletSun Pharmaceutical Industries Ltd.
Defrijet 500mg TabletSun Pharmaceutical Industries Ltd.

५ ब्रान्ड · ३ निर्माता — NepalDoc सूचीमा — पूरै Deferasirox गाइड हेर्नुहोस् →

Store deferasirox tablets at 20°C to 25°C (68°F to 77°F); Protect from moisture.

Storage information from the U.S. FDA-approved label for Deferasirox.

प्रश्न–उत्तर

Desifer 100 DT के हो?

Desifer 100 DT 100mg Tablet भनेको Deferasirox औषधि हो, Natco Pharma ले बनाएको। यो 100mg Tablet रूपमा पाइन्छ।

Desifer 100 DT के का लागि प्रयोग हुन्छ?

Deferasirox Chronic iron overload का लागि प्रयोग हुन्छ।

Desifer 100 DT को सामान्य नाम के हो?

Desifer 100 DT को सामान्य नाम Deferasirox हो।

नेपालमा Deferasirox का कुन कुन ब्रान्ड उपलब्ध छन्?

NepalDoc सूचीमा Deferasirox का ५ वटा ब्रान्ड छन्, ३ निर्माताबाट — जसमा Defrijet 250mg Tablet, Defrijet 500mg Tablet, Desirox 250mg Tablet, Desirox 500mg Tablet पर्छन्।

Desifer 100 DT को मूल्य नेपालमा कति हो?

NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।

पूर्ण औषधि गाइड औषधि बोर्डमा जाँच गर्नुहोस्
+ Safety information

यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।

यो सेयर गर्नुहोस्
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.
No prices are shown — NepalDoc lists medicine information only.